Aperio Group LLC increased its position in shares of Cooper Companies, Inc. (The) (NYSE:COO) by 47.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,890 shares of the medical device company’s stock after buying an additional 6,365 shares during the period. Aperio Group LLC’s holdings in Cooper Companies, Inc. (The) were worth $4,762,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. YorkBridge Wealth Partners LLC raised its stake in shares of Cooper Companies, Inc. (The) by 18.5% in the first quarter. YorkBridge Wealth Partners LLC now owns 520 shares of the medical device company’s stock worth $105,000 after buying an additional 81 shares in the last quarter. Archford Capital Strategies LLC raised its stake in shares of Cooper Companies, Inc. (The) by 116.7% in the first quarter. Archford Capital Strategies LLC now owns 674 shares of the medical device company’s stock worth $135,000 after buying an additional 363 shares in the last quarter. Penserra Capital Management LLC raised its stake in shares of Cooper Companies, Inc. (The) by 9.5% in the first quarter. Penserra Capital Management LLC now owns 782 shares of the medical device company’s stock worth $156,000 after buying an additional 68 shares in the last quarter. Pacer Advisors Inc. raised its stake in shares of Cooper Companies, Inc. (The) by 3.8% in the first quarter. Pacer Advisors Inc. now owns 848 shares of the medical device company’s stock worth $170,000 after buying an additional 31 shares in the last quarter. Finally, Visionary Asset Management Inc. acquired a new stake in shares of Cooper Companies, Inc. (The) during the second quarter worth approximately $201,000. 98.06% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Cooper Companies, Inc. (NYSE:COO) opened at 245.05 on Friday. Cooper Companies, Inc. has a 12 month low of $158.73 and a 12 month high of $256.39. The company has a market cap of $11.97 billion, a PE ratio of 36.74 and a beta of 0.61. The stock has a 50 day moving average of $245.29 and a 200-day moving average of $217.13.
Cooper Companies, Inc. (The) (NYSE:COO) last announced its quarterly earnings data on Thursday, June 1st. The medical device company reported $2.50 earnings per share for the quarter, topping the consensus estimate of $2.25 by $0.25. Cooper Companies, Inc. (The) had a return on equity of 15.88% and a net margin of 16.02%. The company had revenue of $522.40 million during the quarter, compared to analyst estimates of $520.71 million. During the same quarter last year, the firm posted $2.05 EPS. The firm’s revenue for the quarter was up 8.0% on a year-over-year basis. Equities analysts forecast that Cooper Companies, Inc. will post $9.63 earnings per share for the current year.
The company also recently disclosed a semiannual dividend, which was paid on Monday, August 7th. Investors of record on Friday, July 21st were issued a $0.03 dividend. This represents a yield of 0.02%. The ex-dividend date of this dividend was Wednesday, July 19th. Cooper Companies, Inc. (The)’s dividend payout ratio (DPR) is currently 0.90%.
ILLEGAL ACTIVITY NOTICE: “Aperio Group LLC Purchases 6,365 Shares of Cooper Companies, Inc. (The) (NYSE:COO)” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this news story on another site, it was illegally copied and republished in violation of United States & international trademark & copyright laws. The original version of this news story can be viewed at https://stocknewstimes.com/2017/08/19/aperio-group-llc-boosts-position-in-cooper-companies-inc-the-nysecoo-updated-updated.html.
A number of analysts have recently commented on COO shares. BMO Capital Markets reissued an “outperform” rating and issued a $255.00 price objective (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Monday, June 5th. Zacks Investment Research raised shares of Cooper Companies, Inc. (The) from a “hold” rating to a “buy” rating and set a $226.00 price objective on the stock in a research report on Wednesday, May 3rd. Jefferies Group LLC reissued a “buy” rating and issued a $250.00 price objective (up previously from $220.00) on shares of Cooper Companies, Inc. (The) in a research report on Saturday, June 3rd. Stifel Nicolaus boosted their target price on shares of Cooper Companies, Inc. (The) from $220.00 to $231.00 and gave the stock a “buy” rating in a report on Friday, June 2nd. Finally, Piper Jaffray Companies boosted their target price on shares of Cooper Companies, Inc. (The) to $265.00 and gave the stock an “overweight” rating in a report on Wednesday, July 19th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $242.00.
In other Cooper Companies, Inc. (The) news, CEO Paul L. Remmell sold 9,294 shares of Cooper Companies, Inc. (The) stock in a transaction dated Friday, July 14th. The stock was sold at an average price of $248.46, for a total transaction of $2,309,187.24. Following the completion of the transaction, the chief executive officer now owns 6,186 shares of the company’s stock, valued at approximately $1,536,973.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stanley Md Zinberg sold 816 shares of Cooper Companies, Inc. (The) stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $243.14, for a total value of $198,402.24. The disclosure for this sale can be found here. In the last three months, insiders sold 67,331 shares of company stock valued at $16,400,454. 1.60% of the stock is currently owned by insiders.
Cooper Companies, Inc. (The) Company Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.
